Phase I and pharmacokinetics study of a novel anti-CD20 antibody, RO5072759 (GA101), in Japanese patients (Pts) with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) pretreated with rituximab.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: K. Tobinai, M. Ogura, K. Hatake, Y. Kobayashi, M. Mori, T. Uchida, T. Suzuki, Y. Terui, M. Yokoyama, T. Hotta
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2266305207